Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 100 citing articles:

Animal Models of Hypertension: A Scientific Statement From the American Heart Association
Lilach O. Lerman, Theodore W. Kurtz, Rhian M. Touyz, et al.
Hypertension (2019) Vol. 73, Iss. 6
Open Access | Times Cited: 248
Genomics of hypertension: the road to precision medicine
Sandosh Padmanabhan, Anna F. Dominiczak
Nature Reviews Cardiology (2020) Vol. 18, Iss. 4, pp. 235-250
Open Access | Times Cited: 152
The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose–Response Meta-analysis
Xinyu Ge, Liang Zheng, Rulin Zhuang, et al.
Advances in Nutrition (2019) Vol. 11, Iss. 1, pp. 66-76
Open Access | Times Cited: 149
Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
Saroj Chakraborty, Sarah Galla, Xi Cheng, et al.
Cell Reports (2018) Vol. 25, Iss. 3, pp. 677-689.e4
Open Access | Times Cited: 132
Pharmacogenomics of Hypertension Treatment
Jacek Rysz, Beata Franczyk, Magdalena Rysz-Górzyńska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4709-4709
Open Access | Times Cited: 76
Engineering Precision Medicine
Wujin Sun, Junmin Lee, Shiming Zhang, et al.
Advanced Science (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 79
Precision Medicine and Personalized Medicine in Cardiovascular Disease
Gemma Currie, Christian Delles
Advances in experimental medicine and biology (2018), pp. 589-605
Closed Access | Times Cited: 62
Hypertension genetics past, present and future applications
Kaya J. Olczak, Victoria Taylor‐Bateman, Hannah Nicholls, et al.
Journal of Internal Medicine (2021) Vol. 290, Iss. 6, pp. 1130-1152
Open Access | Times Cited: 42
The regulatory landscape of multiple brain regions in outbred heterogeneous stock rats
Daniel Munro, Tengfei Wang, Apurva S. Chitre, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 19, pp. 10882-10895
Open Access | Times Cited: 35
Management of Hypertension in the Elderly and Frail Patient
Luigina Guasti, Marco Ambrosetti, Marco Ferrari, et al.
Drugs & Aging (2022) Vol. 39, Iss. 10, pp. 763-772
Open Access | Times Cited: 33
IL-22 as a target for therapeutic intervention: Current knowledge on its role in various diseases
Pranav Seth, Shweta Dubey
Cytokine (2023) Vol. 169, pp. 156293-156293
Closed Access | Times Cited: 18
siRNA as potential therapeutic strategy for hypertension
Srushti Tanna, Gaurav Doshi, Angel Godad
European Journal of Pharmacology (2024) Vol. 969, pp. 176467-176467
Closed Access | Times Cited: 5
Prospects for Leveraging the Microbiota as Medicine for Hypertension
David J. Durgan, Jasenka Zubcevic, Matam Vijay‐Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 5
Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
Lívia da Cunha Agostini, Nayara Nascimento Toledo Silva, Vanessa A. Belo, et al.
European Journal of Pharmacology (2024) Vol. 981, pp. 176907-176907
Closed Access | Times Cited: 5
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder
Saroj Chakraborty, Juthika Mandal, Tao Yang, et al.
Hypertension (2020) Vol. 75, Iss. 6, pp. 1386-1396
Open Access | Times Cited: 46
<p>Pharmacogenomics And Hypertension: Current Insights</p>
Gustavo H. Oliveira‐Paula, Sherliane Carla Pereira, José E. Tanus‐Santos, et al.
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 341-359
Open Access | Times Cited: 45
Single-cell RNA sequencing reveals cell type- and artery type-specific vascular remodelling in male spontaneously hypertensive rats
Jun Cheng, Wenduo Gu, Ting Lan, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 4, pp. 1202-1216
Open Access | Times Cited: 40
Advances on the Experimental Research in Resistant Hypertension
Maria Cláudia Irigoyen, Cláudia Fetter, Kátia De Angelis
Current Hypertension Reports (2024) Vol. 26, Iss. 12, pp. 475-482
Closed Access | Times Cited: 4
UMOD Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide
Linsay McCallum, Stefanie Lip, Alex McConnachie, et al.
Hypertension (2024) Vol. 81, Iss. 10, pp. 2049-2059
Open Access | Times Cited: 4
Characterizing novel olfactory receptors expressed in the murine renal cortex
Victoria L. Halperin Kuhns, Jason Sanchez, Dylan C. Sarver, et al.
AJP Renal Physiology (2019) Vol. 317, Iss. 1, pp. F172-F186
Open Access | Times Cited: 37
Genomics of Blood Pressure and Hypertension: Extending the Mosaic Theory Toward Stratification
Stefanie Lip, Sandosh Padmanabhan
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 5, pp. 694-705
Open Access | Times Cited: 35
Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage
Saroj Chakraborty, Juthika Mandal, Xi Cheng, et al.
Hypertension (2020) Vol. 76, Iss. 1, pp. 59-72
Open Access | Times Cited: 32
Microbiota are critical for vascular physiology: Germ-free status weakens contractility and induces sex-specific vascular remodeling in mice
Jonnelle M. Edwards, Shaunak Roy, Jeremy C. Tomcho, et al.
Vascular Pharmacology (2019) Vol. 125-126, pp. 106633-106633
Open Access | Times Cited: 30
Machine learning integration of multimodal data identifies key features of blood pressure regulation
Panayiotis Louca, Tran Tran, Clea du Toit, et al.
EBioMedicine (2022) Vol. 84, pp. 104243-104243
Open Access | Times Cited: 18
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
Zining Li, Jialiang Gao, Di Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top